Celltex Therapeutics successfully used to bank stem cells for juvenile idiopathic arthritis treatment

Written by Anuja Vaidya | February 23, 2015 | Print  |

A young patient has successfully used Celltex Therapeutics to culture and bank his own stem cells to be for use in treating his severe case of systemic juvenile idiopathic arthritis.

Celltex Therapeutics is a biotechnology company established to initiate breakthroughs in regenerative medicine, specifically in the autologous stem cell field.


Six-year-old Tucker Beau Hyatt has suffered from juvenile arthritis since he was two. Following the stem cell therapy, vast improvements in Tucker Beau's appetite and his body were noted. He is now able to run and play without pain.

More articles on devices:

5 quick notes on Precision Spine's MD-Max ULIF System: Dr. Donald Kucharzyk
LDR's 4Q revenue up 23.6%: 12 key notes
Orthocell's expands Asia presence; tendon repair therapy used in Hong Kong

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months